A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole
Exclusive Pharma Industry 4 min read After WHO nod, Indian Patient Groups urge GLP-1 inclusion in NLEM With the WHO recommending blockbuster GLP-1 therapies such as Semaglutide and Tirzepatide as essential medicines for diabetes, patient advocates in India are urging their inclusion in the National List of Essential Medicines (NLEM) to enable state procurement, free distribution, and wider affordability
Glutathione l mt hp cht c kh nng chng oxy ha vt tri, gip chng li s tc ng ca cc gc t do, gii c t v loi b cc kim loi nng khi c th, ng thi cng c h min dch v lm chm qu trnh lo ha
doi: 10.1038/s43018-023-00715-8 9 LinYDongYLiuWFanXSunY
The more people who take GLP-1 weight-loss drugs, the faster the US economy could grow, a Goldman Sachs analyst said in a note last month
Pizzimenti, S., Toaldo, C., Pettazzoni, P., Dianzani, M